Skip to main content
Clinical Trials/NCT04562649
NCT04562649
Completed
Not Applicable

Community Health Worker And MHealth to ImProve Viral Suppression

Columbia University3 sites in 1 country300 target enrollmentMay 3, 2021
ConditionsHIV/AIDS

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV/AIDS
Sponsor
Columbia University
Enrollment
300
Locations
3
Primary Endpoint
Number of Virally Suppressed Participants
Status
Completed
Last Updated
last year

Overview

Brief Summary

The overall goal of this study is to evaluate the effects of the CHAMPS intervention for people living with HIV (PLWH) in a randomized controlled trial. The proposed trial is scientifically significant in representing a principled and systematic effort to test the efficacy of a combined community health worker (CHW) and smartphone intervention linked to a smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided by a rigorous theoretical model of supportive accountability and building on preliminary work, this intervention has the potential to enable PLWH to self-manage their ART regimens while CHW monitor their ART adherence in real-time ultimately leading to viral suppression and ART adherence.

Detailed Description

Persons living with HIV (PLWH) now achieve a near-normal life expectancy due to antiretroviral therapy (ART) which has transformed HIV from a terminal diagnosis to a manageable chronic condition. Despite widespread availability of ART in the United States (US), many of the country's approximate 1.1 million PLWH are not fully benefitting from ART due to poor adherence. These suboptimal HIV health outcomes occur at a time when clinicians have limited time and the US healthcare system remains fragmented, further exacerbating the challenges inherent in the lives of underserved, marginalized groups, such as PLWH. Therefore, the development and evaluation of interventions using a cadre of community health workers (CHW) holds promise for addressing these challenges in the US. This study addresses limitations in current research on CHW interventions to improve viral suppression and ART adherence. The investigators propose to build on strong preliminary data to strengthen a community health worker (CHW) intervention using an existing mHealth approach, and provide further information regarding the successful wide-scale implementation of this combination intervention.

Registry
clinicaltrials.gov
Start Date
May 3, 2021
End Date
April 19, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rebecca Schnall, RN, MPH, PhD

Mary Dickey Lindsay Professor of Disease Prevention and Health Promotion

Columbia University

Eligibility Criteria

Inclusion Criteria

  • Be able to communicate and read in English or Spanish
  • Willing to participate in any assigned arm of the intervention
  • Diagnosed with HIV ≥6 months ago
  • Have an HIV-1 RNA level \>200 copies/mL, or have at least one "no-show" visit in the past 12 months, or report being virally unsuppressed in the past 12 months
  • Have ART adherence \<80%, as measured through Single-Item Self-Rating Adherence Scale (SRSI)
  • Own a smartphone

Exclusion Criteria

  • Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment
  • Terminal illness with life expectancy \<6 months
  • Planning to move out of the area in the next 12 months

Outcomes

Primary Outcomes

Number of Virally Suppressed Participants

Time Frame: 6 month follow up, 12 month follow up

The number of virally suppressed participants. Viral suppression defined as viral load of \<200 copies/mL.

Secondary Outcomes

  • Antiretroviral Therapy (ART) Adherence - CleverCap(Up to 12 months)
  • Change in Score on the Self-Rating Scale Item (SRSI)(6 month follow up and 12 month follow up)

Study Sites (3)

Loading locations...

Similar Trials